Stock Ratings / Health Care / ADPT / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Adaptive Biotechnologies Corporation (ADPT) 12-Month Stock Forecast & Price Target Cone

$28.17 -0.70% NASDAQ • Public Delayed / 60s Snapshot

Adaptive Biotechnologies Corporation (ADPT) carries a Roarable Rating of D+ (Sell) with 58/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh money.

ROARABLE D+ • SELL / AVOID Cap $4.50B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+0% Base Target

WHALE OPTIONS TUG-OF-WAR:52% Call Buyers ($2.3M)

48% PutsMax Pain: $28.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your ADPT Position Size: $10,000

Shares at $28.17: 355.0 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $21.97

$7,799

$-2,201 (-22.0%)

12M Consensus BaseTarget $28.17

$10,000

+$0 (+0.0%)

12M Bull Case BreakoutTarget $33.24

$11,800

+$1,800 (+18.0%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$29	74%	A
Goldman SachsSector Coverage Lead	UNDERPERFORM	$31	69%	B
JP MorganUS Large-Cap Research	HOLD	$25	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk

Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring ADPT)

✓Live walkthrough of ADPT's RQD Radar, SEC cash-conversion gap & downside levels
✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
✓Includes instant 24/7 email alert whenever any of your stocks flip to Red

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

ADPT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +88.94%▲ ASCENDING CHANNEL

2026-10-30O $27.36H $27.97L $26.17C $26.64VOL 4.26M

RES: $32.80SUP: $24.26SMA50: $26.38SMA200: $19.60

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ADPT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ADPT Butterfly Map → + Track ADPT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

19.7%/yr Implied 5Y Growth

vs. +54.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ADPT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ADPT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ADPT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

ADPT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is ADPT's 12-month stock price target?

Adaptive Biotechnologies Corporation (ADPT) carries a 12-month consensus base price target of $28.17 (+0% from $28.17), with a bull-case target of $33.24 and a bear-case floor of $21.97.

Is ADPT stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates ADPT D+ (Sell — SELL) with an RQD Confidence score of 58/100.

Direct Sub-Reports: ADPT RQD Cockpit ADPT 12M Forecast ADPT Earnings & Move ADPT Dividends & DRIP ADPT Insiders & 13F ADPT Whale Options ADPT Profit Sankey ADPT News & Why